“The Fastest Growing Pharmaceutical Company of Central India”. The firm was awarded with the prestigious title at the International Business Leadership Awards 2021. The event was hosted at the Hotel Novotel in Goa recently, and the organizers were Faggan Singh Kulaste, Minister of Rural Development and Minister of Steel, the Government of India; Pandit Sunil Bharala, Chairman/Minister of State for Labour Welfare, the Government of Uttar Pradesh; and the popular Bollywood actress Poonam Dhillon.
India exported medications and pharmaceuticals worth US$ 24.44 billion in the financial year 2021 and emerged as the world’s 12th highest exporter of medical products. Moreover, Signity Pharmaceuticals is attempting to establish itself as a top supplier of nutraceutical goods in this environment. They have already established a strong recognition for selling standard nutraceutical goods to Europe, America, and Southeast Asia. At present, they are attempting to expand their research and development activities in order to further establish their dominance in the international pharmaceutical sector. Additionally, they also developed India’s first unique liver preparation. Signity has also filed a patent application for this.
Shridhar Dhavle, director of the firm, commented on the accomplishment. He expressed delight over the company’s success and progressive journey over the years. He said, “It has been a great journey for us. We have started our journey with a vision of introducing innovative drug formulations as an aid to the country’s healthcare system. Our unique nutraceutical formulations have already gained acknowledgment across the country. We express our deep gratitude to the medical fraternity and all our well-wishers for their wholehearted support and confidence in us which always inspired us to excel and grow during the last 11 years.”
Signity is all prepared to meet the demands of the current medical infrastructure with unique and world-class medicine formulations under the direction of Bhupendra Marliwar, Shridhar Dhavle, and Vishal Mulani. Signity Pharmaceuticals produce and market a diverse portfolio of industry-leading pharmaceuticals, including anti-infectives, life-saving medications, hepatoprotective drugs, immunomodulators, neurotropics, enhanced pain killers, nutraceutical formulations, and respiratory formulations. The firm continuously aims at revolutionizing the whole medical industry.
